Dr. Chari on Investigational Belantamab Mafodotin Combos in Myeloma | OncLive
Dr. Chari on Investigational Belantamab Mafodotin Combos in …
Aug 20, 2020
onclive.com
Belantamab Mafodotin Dosing Strategies in Patients with RRMM
Belantamab Mafodotin Dosing Strategies in Patients with RRMM
Mar 14, 2022
onclive.com
Does Belantamab Have a Place in Multiple Myeloma Treatment?
Does Belantamab Have a Place in Multiple Myeloma Treatment?
Mar 13, 2023
onclive.com
Managing AEs With Belantamab Mafodotin in Relapsed/Refractory Myeloma | OncLive
Managing AEs With Belantamab Mafodotin in Relapsed/Refractory …
1 week ago
onclive.com
39 reactions | In this video, Dr. Durie discusses how belantamab mafodotin, targets multiple myeloma cells and why this new drug is important for relapsed/refractory myeloma patients. | International Myeloma Foundation | Facebook
3:16
39 reactions | In this video, Dr. Durie discusses how belantamab mafod…
502 views3 weeks ago
FacebookInternational Myeloma Foundation
Dr. Gasparetto on Managing Keratopathy Associated With Belantamab Mafodotin in Myeloma
Dr. Gasparetto on Managing Keratopathy Associated With Bela…
Dec 15, 2021
onclive.com
Blenrep (belantamab mafodotin) is an antibody drug conjugate—it hooks onto myeloma cells and delivers a toxic ‘backpack’ to destroy them.’ New data show adding Blenrep to standard treatments improves outcomes, especially in high-risk myeloma. #AskTheIMF | International Myeloma Foundation
1:07
Blenrep (belantamab mafodotin) is an antibody drug conjugate—it ho…
4.2K views1 month ago
FacebookInternational Myeloma Foundation
Dr Krishnan on the Evolving Role of Belantamab Mafodotin in Multiple …
4 days ago
onclive.com
Dr. Callander on the Expanding Role of Belantamab Mafodotin in Multip…
Jan 28, 2021
onclive.com
Dr. Vesole on the Mechanism of Action of Belantamab Mafodotin i…
Nov 12, 2020
onclive.com
Dr Mateos on Belantamab Mafodotin Plus Bortezomib/Dexamethasone i…
1 week ago
onclive.com
Dr. Finn on the Utility of Belantamab Mafodotin in Late Relapsed Multipl…
Jan 17, 2022
onclive.com
1:11
Have you ever been treated for #myeloma with belantamab mafod…
309 views9 months ago
FacebookInternational Myeloma Foundation
DREAMM-7 Update: Subgroup Analyses From a Phase 3 Trial of …
Jun 28, 2024
onclive.com
Dr Kin on the Withdrawal of Belantamab Mafodotin in R/R Multi…
1 week ago
onclive.com
Dr. Martin on the Safety Profile of Belantamab Mafodotin in R/R Multi…
3 weeks ago
onclive.com
4:13
Results from part one of the Phase I/II DREAMM-20 trial of belantama…
5 views2 weeks ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:57
Belantamab plus pomalidomide and dexamethasone as a maintenance …
35 views2 weeks ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
The impact of prior exposure to belantamab on outcomes with ide …
35 views8 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
6:58
Mieloma multiplo, belantamb mafodotin conferma efficacia e sic…
280 viewsDec 19, 2022
YouTubePharmaStarTV
Safety and preliminary efficacy of elotuzumab and belantamab mafo…
68 viewsJul 1, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:43
The role of belantamab mafodotin in multiple myeloma: the DREAMM-…
424 viewsMay 31, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Belantamab mafodotin: ocular toxicity
212 viewsDec 7, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
Results of a Phase I study of belantamab mafodotin in combina…
83 viewsSep 30, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Belantamab Mafodotin or BLENREP (BCMA) for fighting multiple myelo…
98 viewsJul 8, 2022
YouTube
Mieloma multiplo r/r, con belantamab in combinazione tripli…
787 viewsMar 7, 2024
YouTubePharmaStarTV
Belentamab Plus Cyclophosphamide & Dexamethas…
58 views9 months ago
YouTubeHealthTree Foundation
Managing belantamab mafodotin-associated corneal adverse event…
109 viewsMar 19, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
Dr. Raje on the Potential Utility of Belantamab Mafodotin in Multiple …
130 viewsApr 23, 2020
YouTubeOncLive
See more videos
Static thumbnail place holder